Latest PRVB reports update at 2023-03-29: 2022 ∙ 2021 ∙ 2020

Provention Bio PRVB

$ 24.98 0.0%

Provention Bio Balance Sheet 2011-2024 | PRVB

Annual Balance Sheet Provention Bio

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-20.4 M	-77.5 M	-	-39.2 M	-58.5 M	-21.8 M	-	-	-	-	-	-
Long Term Debt	23.5 M	590 K	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	151 K	125 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	998 K	-	-	-	-	-	-
Total Current Liabilities	90.4 M	22.8 M	16.7 M	3.84 M	1.87 M	-	-	-	-	-	-	-
Total Liabilities	115 M	24.9 M	17.4 M	3.84 M	1.87 M	2.28 M	290 K	-	-	-	-	-
Deferred Revenue	17.7 M	5.6 M	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-406 M	-292 M	-178 M	-79.1 M	-35.8 M	-9.3 M	-165 K	-	-	-	-	-
Total Assets	237 M	136 M	129 M	86 M	61.5 M	22.4 M	125 K	-	-	-	-	-
Cash and Cash Equivalents	44 M	78.2 M	102 M	39.2 M	58.5 M	21.8 M	-	-	-	-	-	-
Book Value	122 M	111 M	111 M	82.2 M	59.7 M	20.2 M	-165 K	-	-	-	-	-
Total Shareholders Equity	122 M	111 M	111 M	82.2 M	59.7 M	-6.03 M	-165 K	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Provention Bio

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	23.3 M	-	555 K	590 K	624 K	655 K	686 K	715 K	715 K	715 K	715 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	49.1 M	-	28.3 M	24.9 M	23.8 M	25.3 M	29.9 M	17.4 M	17.4 M	17.4 M	17.4 M	3.84 M	-	-	-	1.87 M	1.23 M	2.99 M	-	2.28 M	2.28 M	2.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	7.78 M	-	7.37 M	5.6 M	5.49 M	7 M	4.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-372 M	-	-314 M	-292 M	-266 M	-239 M	-210 M	-178 M	-178 M	-178 M	-178 M	-79.1 M	-79.1 M	-79.1 M	-79.1 M	-35.8 M	-35.8 M	-35.8 M	-35.8 M	-9.3 M	-9.3 M	-9.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	194 M	-	122 M	136 M	158 M	183 M	214 M	129 M	129 M	129 M	129 M	86 M	86 M	86 M	86 M	61.5 M	61.5 M	61.5 M	61.5 M	22.4 M	22.4 M	22.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	102 M	-	74.9 M	78.2 M	139 M	152 M	180 M	102 M	102 M	102 M	102 M	39.2 M	39.2 M	39.2 M	39.2 M	58.5 M	58.5 M	58.5 M	58.5 M	21.8 M	21.8 M	21.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	145 M	-	94.2 M	111 M	134 M	158 M	184 M	111 M	111 M	111 M	111 M	82.2 M	86 M	86 M	86 M	59.7 M	60.3 M	58.5 M	61.5 M	20.2 M	20.2 M	20.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	145 M	-	94.2 M	111 M	134 M	158 M	184 M	111 M	111 M	111 M	111 M	82.2 M	82.2 M	82.2 M	82.2 M	59.7 M	59.7 M	59.7 M	59.7 M	-6.03 M	-6.03 M	-6.03 M	-	-165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency